To the best of our knowledge, we demonstrated for the first time a high prevalence of somatic missense mutations (23.2%) in the PIK3CA gene in human BP-NETs that is comparable to the mutational frequency of the PIK3CA gene in other types of human cancers (12–14,26,27). This evidence concerns the gene PIK3CA and cancer.